Robot pets

The pet branch of companion robotics is getting interesting.

Some are toys with excellent character design. Some recognise you, navigate the house and build interaction history. A few are explicitly being engineered around long-term attachment. They belong in the same conversation, but they are not interchangeable.

A person hugging a LOVOT companion robot
Photo: GROOVE X / LOVOT

The most advanced robot pet may be the one that does fewer useful things on purpose.

LOVOT is designed around warmth, gaze, touch and recognition rather than chores. Familiar is aiming at a similar emotional territory with much more ambitious memory and social-context claims. At the cheaper end, Moflin and Loona show how quickly the category is spreading into normal consumer prices.

Casio Moflin

Casio Moflin

Palm-sized furry emotional companion with two-axis movement; it does not walk around the home.

£369UK retail
Verified
Loona Petbot Premium

Loona Petbot Premium

Wheeled expressive robot pet with face recognition, games, autonomous charging and GPT-enabled conversation.

£378 at Amazon UK todayUK retail route
Verified + maker claims
LOVOT 3.0

LOVOT 3.0

Autonomous warm-bodied social robot designed to be cared for and form a slow relationship rather than perform chores.

Regional pricingJapan / selected regions
Verified
Familiar

Familiar

Dog-sized, four-legged, pet-inspired physical AI companion designed around touch, household memory and non-verbal emotional behaviour.

TBADevelopment / waitlist
Prototype / maker claims

The useful test is not “does it look like a pet?” It is whether the behaviour still feels worth engaging with after the novelty has worn off.

That is where memory, recognition, physical responsiveness and reliability matter. A clever animation can be charming for an afternoon. A companion product has to survive repeated contact without becoming predictable or irritating.

We also separate emotional-product claims from clinical claims. A robot can be enjoyable, comforting or habit-forming without being a medical treatment. When manufacturers publish wellbeing studies, we track the study design rather than turning the conclusion into marketing copy.